“Apple Inc.’s shifting disclosures about Chief Executive Officer Steve Jobs’s health are forcing regulators into new legal territory, balancing investors’ right to information against a last bastion of executive privacy,” Karen Gullo, Connie Guglielmo and David Scheer report for Bloomberg.
“The Securities and Exchange Commission’s inquiry, reported by Bloomberg News last week, is likely to examine how Jobs’s diagnoses unfolded and why Apple announced Jan. 14 that he was taking a five-month medical leave, nine days after saying he needed ‘relatively simple’ treatment for a nutritional ailment,” Gullo, Guglielmo and Scheer report. “The inquiry is being led by the SEC’s San Francisco office, a person familiar with the matter said.”
“Regulators have rarely pried into an executive’s health and may set a precedent if they bring a case,” Gullo, Guglielmo and Scheer report.
Full article here.
[Attribution: MacNN.]
